A US (ultrasound) thyroid test is a painless imaging exam that uses high-frequency sound waves to create detailed pictures of your thyroid gland and the surrounding structures in your neck. It’s the most sensitive imaging tool available for evaluating the thyroid, and it’s typically the first test ordered when a doctor feels a lump, suspects a nodule, or needs to investigate abnormal thyroid blood work. The exam takes roughly 15 to 30 minutes, involves no radiation, and requires little to no preparation.
How the Test Works
During a thyroid ultrasound, a technologist or radiologist places a small handheld probe on the skin of your neck. That probe sends out sound waves at frequencies between 7 and 15 MHz, which bounce off the tissues inside your neck and return as echoes. A computer translates those echoes into a real-time image on a screen. The examiner scans in two directions (side to side and top to bottom) to build a complete picture of the gland.
Two main imaging modes are used together. Gray-scale imaging shows the structure of the thyroid: its size, shape, and whether any lumps are present. Color Doppler imaging maps blood flow, revealing whether a nodule or the gland itself has an unusual blood supply. Increased or abnormal blood flow patterns can be a clue that something needs closer attention.
Why Your Doctor Ordered It
The most common reason is a suspected or known thyroid nodule. Your doctor may have felt something during a neck exam, or a nodule may have shown up unexpectedly on a different scan, like a CT of the neck or a carotid artery ultrasound. European and American guidelines agree that a full neck ultrasound should be performed whenever nodular thyroid disease is suspected, regardless of whether the nodule is causing symptoms.
Other common reasons include evaluating an enlarged thyroid (goiter), monitoring a nodule that was previously biopsied and found to be benign, checking nearby lymph nodes for signs of spread in someone with thyroid cancer, and getting a closer look when blood tests show thyroid hormone levels are off. The ultrasound gives your doctor structural information that blood tests alone can’t provide.
What to Expect During the Exam
You’ll lie on your back on an exam table with a small towel or pillow placed behind your neck to tilt your head back slightly and expose the front of your throat. A technologist applies a clear gel to your skin (it helps the sound waves travel) and then gently presses the probe against different areas of your neck. You may feel light pressure, but it shouldn’t be painful.
There’s generally no special preparation. You don’t need to fast, stop medications, or drink extra water beforehand. You can eat, drink, and take your usual medications the morning of the exam. The images are typically reviewed by a radiologist, who sends a written report to the doctor who ordered the test.
What the Images Can Reveal
The ultrasound captures several characteristics of any nodule it finds: its location, size, shape, edges, internal brightness compared to surrounding tissue, whether it contains fluid or solid material, and its blood flow pattern. Each of these features helps determine whether the nodule looks harmless or needs further investigation.
Features that raise concern for cancer include a nodule that appears darker than the surrounding thyroid tissue (called hypoechoic), blurry or irregular edges, and tiny bright specks of calcification inside the nodule. Those small calcifications are the single most reliable ultrasound sign of malignancy, with a specificity of 93% and a positive predictive value of 70%. Papillary thyroid cancer, the most common type, is predominantly solid, darker than surrounding tissue in 77% to 90% of cases, and contains microcalcifications in 25% to 90% of cases.
A nodule that appears darker than normal tissue carries about a 26% chance of being malignant. But most thyroid nodules are benign. The ultrasound’s job is to sort out which ones deserve a closer look through biopsy and which ones can simply be monitored over time.
How Nodules Are Scored
Radiologists use a standardized scoring system called ACR TI-RADS (Thyroid Imaging Reporting and Data System) to rate each nodule on a scale from TR1 to TR5. Points are assigned based on what the nodule looks like, and the total determines the category.
- TR1 and TR2 (0 to 2 points): Benign or not suspicious. The risk of cancer is under 2%. No biopsy is needed.
- TR3 (3 points): Mildly suspicious. Biopsy is recommended only if the nodule is 2.5 cm or larger.
- TR4 (4 to 6 points): Moderately suspicious. Biopsy is recommended at 1.5 cm or larger. The predicted malignancy risk is roughly 5% to 20%.
- TR5 (7+ points): Highly suspicious. Biopsy is recommended at 1 cm or larger. The malignancy risk exceeds 20%.
In practice, the real-world cancer rates found in one study were 0% for TR1 and TR2, about 7% for TR3, 31% for TR4, and 78% for TR5. This scoring system helps avoid unnecessary biopsies on low-risk nodules while flagging the ones that genuinely need tissue sampling.
Lymph Node Evaluation
A thyroid ultrasound doesn’t stop at the gland itself. The radiologist also examines the lymph nodes in your neck, checking both the central compartment (the area between the two carotid arteries) and the lateral compartments (extending out toward the sides of the neck). Ultrasound can detect abnormal lymph nodes as small as 5 mm in diameter.
Signs that a lymph node may contain cancer cells include an unusually round shape, loss of the normal fatty center, tiny calcifications, irregular fluid-filled areas, and abnormal brightness. This part of the exam is especially important for people already diagnosed with thyroid cancer, because it helps surgeons plan the extent of any operation and guides decisions about further treatment.
Ultrasound vs. Nuclear Thyroid Scan
A thyroid ultrasound and a nuclear thyroid scan (scintigraphy) answer different questions. Ultrasound shows anatomy: the size, shape, and physical characteristics of the gland and any nodules. A nuclear scan shows function: whether areas of the thyroid are overactive, underactive, or normal, based on how much radioactive tracer they absorb.
Ultrasound is better at identifying structural details and has higher specificity, meaning it’s less likely to produce a false alarm. Nuclear scans are sometimes better at detecting functional abnormalities, such as a “hot” nodule that’s overproducing thyroid hormone. In many cases the two tests complement each other, and your doctor may order both if the clinical picture is unclear. When combined, the two methods together reach a specificity as high as 95%.
What Happens After the Test
If the ultrasound shows nothing concerning, or if your nodule scores TR1 or TR2, you may not need any follow-up at all, particularly if you’re older, in generally good health, and not experiencing symptoms. For benign-appearing nodules that are worth keeping an eye on, current evidence supports repeat ultrasound in 2 to 4 years rather than the older recommendation of 6 to 18 months. A younger person with a larger nodule (say, 3 cm) may benefit from a repeat scan closer to the 2-year mark.
If the nodule scores TR3 or higher and meets the size threshold for its category, the next step is usually a fine-needle aspiration biopsy. This is a separate procedure, often done under ultrasound guidance, where a thin needle collects a small sample of cells from the nodule for examination under a microscope. The biopsy is the only way to confirm whether a suspicious-looking nodule is actually cancerous or just has worrisome features on imaging. Standard ultrasound alone has a sensitivity of about 77% and specificity of 86% for distinguishing benign from malignant nodules, but when combined with newer techniques like elastography (which measures tissue stiffness), accuracy climbs above 95%.